Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Dendritic cells, macrophages, NK and CD8+ T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B.

Lucinda N, Figueiredo MM, Pessoa NL, Santos BS, Lima GK, Freitas AM, Machado AM, Kroon EG, Antonelli LR, Campos MA.

Virol J. 2017 Feb 21;14(1):37. doi: 10.1186/s12985-017-0692-x.

2.

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Liang Y, Yang K, Guo J, Wroblewska J, Fu YX, Peng H.

Sci Rep. 2015 May 20;5:10406. doi: 10.1038/srep10406.

3.

Novel drugs targeting Toll-like receptors for antiviral therapy.

Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC.

Future Virol. 2014 Sep;9(9):811-829.

4.

Transcriptome analysis of porcine thymus following porcine cytomegalovirus infection.

Liu X, Xu Z, Zhu L, Liao S, Guo W.

PLoS One. 2014 Nov 25;9(11):e113921. doi: 10.1371/journal.pone.0113921. eCollection 2014 Nov 25.

5.

Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia.

Zolini GP, Lima GK, Lucinda N, Silva MA, Dias MF, Pessoa NL, Coura BP, Cartelle CT, Arantes RM, Kroon EG, Campos MA.

J Neuroinflammation. 2014 Jan 30;11:20. doi: 10.1186/1742-2094-11-20.

6.

MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Davies ML, Sei JJ, Siciliano NA, Xu RH, Roscoe F, Sigal LJ, Eisenlohr LC, Norbury CC.

J Virol. 2014 Mar;88(6):3557-67. doi: 10.1128/JVI.02776-13. Epub 2014 Jan 8.

7.

Toll-like receptors in antiviral innate immunity.

Lester SN, Li K.

J Mol Biol. 2014 Mar 20;426(6):1246-64. doi: 10.1016/j.jmb.2013.11.024. Epub 2013 Dec 3. Review.

8.

Recognition of herpes simplex viruses: toll-like receptors and beyond.

Ma Y, He B.

J Mol Biol. 2014 Mar 20;426(6):1133-47. doi: 10.1016/j.jmb.2013.11.012. Epub 2013 Nov 19. Review.

9.

Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Caignard G, Leiva-Torres GA, Leney-Greene M, Charbonneau B, Dumaine A, Fodil-Cornu N, Pyzik M, Cingolani P, Schwartzentruber J, Dupaul-Chicoine J, Guo H, Saleh M, Veillette A, Lathrop M, Blanchette M, Majewski J, Pearson A, Vidal SM.

PLoS Pathog. 2013 Sep;9(9):e1003637. doi: 10.1371/journal.ppat.1003637. Epub 2013 Sep 12.

10.

The case for immunomodulatory approaches in treating HSV encephalitis.

Ramakrishna C, Openshaw H, Cantin EM.

Future Virol. 2013 Mar 1;8(3):259-272.

11.

Novel approaches and challenges to treatment of central nervous system viral infections.

Nath A, Tyler KL.

Ann Neurol. 2013 Sep;74(3):412-22. doi: 10.1002/ana.23988. Review.

12.

Both TRIF and IPS-1 adaptor proteins contribute to the cerebral innate immune response against herpes simplex virus 1 infection.

Menasria R, Boivin N, Lebel M, Piret J, Gosselin J, Boivin G.

J Virol. 2013 Jul;87(13):7301-8. doi: 10.1128/JVI.00591-13. Epub 2013 Apr 17.

13.

Herpes simplex virus US3 tegument protein inhibits Toll-like receptor 2 signaling at or before TRAF6 ubiquitination.

Sen J, Liu X, Roller R, Knipe DM.

Virology. 2013 May 10;439(2):65-73. doi: 10.1016/j.virol.2013.01.026. Epub 2013 Mar 7.

14.

Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.

Tan IL, McArthur JC, Venkatesan A, Nath A.

Neurology. 2012 Nov 20;79(21):2125-32. doi: 10.1212/WNL.0b013e3182752ceb. Epub 2012 Nov 7.

15.

Herpes keratitis.

Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL.

Prog Retin Eye Res. 2013 Jan;32:88-101. doi: 10.1016/j.preteyeres.2012.08.002. Epub 2012 Aug 27. Review.

16.

Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation.

Furr SR, Marriott I.

Front Microbiol. 2012 Jun 20;3:201. doi: 10.3389/fmicb.2012.00201. eCollection 2012 Jun 20.

17.

The Role of TLR2 in Infection and Immunity.

Oliveira-Nascimento L, Massari P, Wetzler LM.

Front Immunol. 2012 Apr 18;3:79. doi: 10.3389/fimmu.2012.00079. eCollection 2012 Apr 18.

18.

Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment.

Schachtele SJ, Hu S, Lokensgard JR.

PLoS One. 2012;7(4):e36216. doi: 10.1371/journal.pone.0036216. Epub 2012 Apr 27.

19.

The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections.

Schuster P, Boscheinen JB, Tennert K, Schmidt B.

Adv Virol. 2011;2011:679271. doi: 10.1155/2011/679271. Epub 2011 Mar 31.

20.

Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.

Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA.

J Virol. 2012 Feb;86(4):2273-81. doi: 10.1128/JVI.06010-11. Epub 2011 Dec 14.

Supplemental Content

Support Center